Clariane SE (EPA:CLARI)
France · Delayed Price · Currency is EUR 3.460
+0.028 (0.82%)
Nov 13, 2025, 5:35 PM CET
Clariane SE Revenue
Clariane SE had revenue of 2.66B EUR in the half year ending June 30, 2025, with 8.23% growth. This brings the company's revenue in the last twelve months to 5.31B, up 2.70% year-over-year. In the year 2024, Clariane SE had annual revenue of 5.28B with 5.73% growth.
Revenue (ttm)
5.31B
Revenue Growth
+2.70%
P/S Ratio
0.23
Revenue / Employee
85.92K
Employees
61,798
Market Cap
1.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.28B | 286.17M | 5.73% |
| Dec 31, 2023 | 5.00B | 557.29M | 12.56% |
| Dec 31, 2022 | 4.44B | 300.99M | 7.27% |
| Dec 31, 2021 | 4.14B | 364.40M | 9.66% |
| Dec 31, 2020 | 3.77B | 160.41M | 4.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.93B |
| EssilorLuxottica Société anonyme | 27.24B |
| Eurofins Scientific SE | 7.14B |
| emeis Société anonyme | 5.77B |
| Ramsay Générale de Santé | 5.24B |
| bioMérieux | 4.12B |
| Ipsen | 3.76B |
| Sartorius Stedim Biotech | 2.95B |